Free Trial

Stryker (SYK) Stock Price, News & Analysis

Stryker logo
$366.49 +1.89 (+0.52%)
(As of 05:45 PM ET)

About Stryker Stock (NYSE:SYK)

Key Stats

Today's Range
$362.44
$367.26
50-Day Range
$352.82
$392.15
52-Week Range
$292.43
$398.20
Volume
1.46 million shs
Average Volume
1.27 million shs
Market Capitalization
$139.71 billion
P/E Ratio
39.28
Dividend Yield
0.92%
Price Target
$405.80
Consensus Rating
Moderate Buy

Company Overview

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Stryker Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
99th Percentile Overall Score

SYK MarketRank™: 

Stryker scored higher than 99% of companies evaluated by MarketBeat, and ranked 18th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.85, and is based on 17 buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Stryker has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Stryker's stock forecast and price target.
  • Earnings Growth

    Earnings for Stryker are expected to grow by 12.27% in the coming year, from $12.06 to $13.54 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stryker is 39.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 112.36.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stryker is 39.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 87.05.

  • Price to Earnings Growth Ratio

    Stryker has a PEG Ratio of 2.82. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stryker has a P/B Ratio of 7.49. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.19% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently decreased by 11.11%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Stryker has a dividend yield of 0.88%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Stryker has been increasing its dividend for 32 years.

  • Dividend Coverage

    The dividend payout ratio of Stryker is 36.01%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Stryker will have a dividend payout ratio of 24.82% next year. This indicates that Stryker will be able to sustain or increase its dividend.

  • Read more about Stryker's dividend.
  • Percentage of Shares Shorted

    1.19% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 3.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently decreased by 11.11%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Stryker has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Stryker this week, compared to 15 articles on an average week.
  • Search Interest

    Only 14 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.
  • MarketBeat Follows

    Only 16 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,131,303.00 in company stock.

  • Percentage Held by Insiders

    Only 5.50% of the stock of Stryker is held by insiders.

  • Percentage Held by Institutions

    77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stryker's insider trading history.
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

February 2025 Options Now Available For Stryker (SYK)
TD Cowen Sticks to Its Buy Rating for Stryker (SYK)
No one’s talking about these Trump trades
As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”
RBC Capital Sticks to Their Buy Rating for Stryker (SYK)
Reasons to Invest in Stryker Corp. (SYK)
Reasons to Invest in Stryker Corp. (SYK)
See More Headlines

SYK Stock Analysis - Frequently Asked Questions

Stryker's stock was trading at $299.46 at the beginning of the year. Since then, SYK shares have increased by 22.4% and is now trading at $366.49.
View the best growth stocks for 2024 here
.

Stryker Co. (NYSE:SYK) released its quarterly earnings results on Tuesday, October, 29th. The medical technology company reported $2.87 earnings per share for the quarter, topping the consensus estimate of $2.77 by $0.10. Stryker's quarterly revenue was up 11.9% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Stryker: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and more.

Stryker's top institutional shareholders include Greenleaf Trust (4.86%), State Street Corp (3.83%), Wellington Management Group LLP (2.65%) and FMR LLC (1.92%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein.
View institutional ownership trends
.

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

Ex-Dividend for 10/31 Dividend
9/30/2024
Last Earnings
10/29/2024
Dividend Payable
10/31/2024
Today
12/23/2024
Ex-Dividend for 1/31 Dividend
12/31/2024
Fiscal Year End
12/31/2024
Dividend Payable
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
CUSIP
86366710
Employees
52,000
Year Founded
1941

Price Target and Rating

Average Stock Price Target
$405.80
High Stock Price Target
$450.00
Low Stock Price Target
$360.00
Potential Upside/Downside
+10.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.85
Research Coverage
20 Analysts

Profitability

Net Income
$3.17 billion
Pretax Margin
19.07%

Debt

Sales & Book Value

Annual Sales
$21.97 billion
Cash Flow
$13.12 per share
Book Value
$48.94 per share

Miscellaneous

Free Float
358,724,000
Market Cap
$139.71 billion
Optionable
Optionable
Beta
0.94

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NYSE:SYK) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners